Skip to content

All recalls FDA

FDADrugsRecalled Status: Closed by the agency

Lupin Pharmaceuticals Inc. recalls clomiPRAMINE hydrochloride Capsules USP

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.
Products
  • clomiPRAMINE hydrochloride Capsules USP
Where it was sold

USA nationwide

Nationwide

Units affected
2724 bottles
About this recall
clomiPRAMINE hydrochloride Capsules USP, 25 mg, 100-count bottle, Rx only, Manufactured For: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, United States, Manufactured By: Lupin Limited, Nagpur, 441 108 INDIA, NDC 68180-492-01